MKC-1 (Standard)

• Description:

  MKC-1 (Standard) is the analytical standard of MKC-1. This product is intended for research and analytical applications. MKC-1 (Ro-31-7453) is an orally active and potent cell cycle inhibitor with broad antitumor activity. MKC-1 inhibits the Akt/mTOR pathway. MKC-1 arrests cellular mitosis and induces cell apoptosis by binding to a number of different cellular proteins including tubulin and members of the importin β family[1][2][3].

• UNSPSC:

  12352100

• Target:

  Akt; Apoptosis; Microtubule/Tubulin; Mitosis; mTOR; Reference Standards

• Related Pathways:

  Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Others; PI3K/Akt/mTOR

• Field of Research:

  Cancer

• Smiles:

  O=C (C (C1=CN (C) C2=C1C=CC=C2) =C3C4=CN (C) C5=C4C=CC ([N+] ([O-]) =O) =C5) NC3=O

• Molecular Formula:

  C22H16N4O4

• Molecular Weight:

  400.39

• References & Citations:

  [1]Wang M, et al. The first design and synthesis of [11C]MKC-1 ([11C]Ro 31-7453), a new potential PET cancer imaging agent. Nucl Med Biol. 2010 Oct;37 (7) :763-75.|[2]Burke P, et al. MKC-1 significantly increases survival of mice bearing renal cell carcinoma Caki-1 xenograft tumors through inhibition of the Akt/mTOR pathway[J]. Molecular Cancer Therapeutics, 2007 (12) :3524S-3525S.|[3]Faris JE, et al. A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer. Invest New Drugs. 2012 Aug;30 (4) :1614-20.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference Standards

• CAS Number:

  125313-92-0